Experimental cancer therapeutics delivered to tumors via nanoparticles could provide a safer and more effective therapy than conventional chemotherapy.
The Scientist
Most Recent
A new class of immune cell could protect against type 1 diabetes by suppressing other immune cells.
Research Associate, Perelman School of Medicine, University of Pennsylvania. Age: 27
Sorting out T-cell functional and phenotypic heterogeneity depends on studying single cells.
Viral infections of the central nervous system may trigger cytokines that induce seizures.
Researchers are using modern experimental tools to probe the mysterious molecular pathways that lead to premature labor and birth.
Some notable quotes from this week’s meeting on cancer research
Researchers have genetically engineered a virus that is deadly to chickens and found that it can kill prostate cancer in vitro.
Physicist-turned-oncologist Robert Austin argues that cancer is a natural consequence of our rapid evolution.
Scientists develop a gel that mimics mollusc glue to coat the insides of blood vessels.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
